Literature DB >> 11063658

Predictive factors for residual disease in subsequent hysterectomy following conization for CIN III.

C H Lu1, F S Liu, J J Tseng, E S Ho.   

Abstract

OBJECTIVE: The aim of this study was to determine predictive factors for post-cone residual disease in subsequent hysterectomy for CIN III.
METHODS: From June 1994 to June 1999, 120 patients with CIN III who received hysterectomy within 6 months of conization regardless of marginal status were identified from 1450 conization cases. The demographic features and pathologic parameters were analyzed for the predictive rate of post-cone residual disease.
RESULTS: Age >==50 years and parity >==5 were significant factors associated with residual disease. The incidence of residual disease was 56.5 and 29. 3% in patients >==50 and <50 years, respectively, and 61.8 and 36.0% in patients with parity >==5 and <5. Post-cone endocervical curettage (ECC) and multiple-quadrant disease were the only pathologic predictive factors identified. The incidence of residual disease was 64.6 and 29.2% in patients with positive ECC and negative ECC, respectively, and 48.4 and 25.9% in patient with multiple-quadrant disease and one- or two-quadrant disease. Other pathologic parameters, including endocervical margins, ectocervical margins, endocervical gland involvement, and depth of conization, were not predictive of residual disease. When ECC was combined individually with age, endocervical margins, or multiple-quadrant disease, there was no increase of positive predictive rate.
CONCLUSIONS: (1) Age 50 years or more and parity >==5 were two demographic features that predicted post-cone residual disease. (2) ECC and multiple-quadrant disease were the only pathologic parameters that predicted post-cone residual disease. (3) With the appropriate application of the predictive factors, post-cone hysterectomy may be further decreased. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 11063658     DOI: 10.1006/gyno.2000.5949

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia.

Authors:  Jeong-Yeol Park; Jaeman Bae; Myong Cheol Lim; So Yi Lim; Dong-Ock Lee; Sokbom Kang; Sang-Yoon Park; Byung-Ho Nam; Sang-Soo Seo
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

2.  Clinical Outcomes Associated with Endocervical Glandular Involvement in Patients with Cervical Intraepithelial Neoplasia III.

Authors:  Nae Ry Kim; Zee Hae Baek; A Jin Lee; Eun Jung Yang; Yung-Taek Ouh; Mi Kyung Kim; Seung-Hyuk Shim; Sun Joo Lee; Tae Jin Kim; Kyeong A So
Journal:  J Clin Med       Date:  2022-05-25       Impact factor: 4.964

3.  Predicting persistent/recurrent disease in the cervix after excisional biopsy.

Authors:  Sanjay M Ramchandani; Karen L Houck; Enrique Hernandez; John P Gaughan
Journal:  MedGenMed       Date:  2007-04-30

4.  Cytohistological correlation of endocervical gland involvement with high-grade squamous intraepithelial lesions.

Authors:  G Kir; Mh Karabulut; Ms Yilmaz; Cs Topal; A Gocmen
Journal:  J Cytol       Date:  2012-04       Impact factor: 1.000

5.  A human papillomavirus (HPV)-16 or HPV-18 genotype is a reliable predictor of residual disease in a subsequent hysterectomy following a loop electrosurgical excision procedure for cervical intraepithelial neoplasia 3.

Authors:  Woo Dae Kang; U Chul Ju; Seok Mo Kim
Journal:  J Gynecol Oncol       Date:  2015-10-08       Impact factor: 4.401

6.  Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization.

Authors:  Hyeyoon Chang; Jin Hwa Hong; Jae Kwan Lee; Hyun Woong Cho; Yung Taek Ouh; Kyung Jin Min; Kyeong A So
Journal:  J Gynecol Oncol       Date:  2018-01-29       Impact factor: 4.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.